INSIGHTS
Ideas for the decisions between science and scale
Practical thinking on programme strategy, AI assurance and expert operating models—written to be used in a leadership conversation, not to fill a content calendar.
VED working method
- 01Point of view
- 02Evidence
- 03Action
FEATURED
Current perspectives
Why drug-development AI needs expert evaluation—not just impressive demos
A practical framework for context, rubrics, failure modes and human accountability.
Explore BIOTECH OPERATING MODELThe first 90 days of fractional regulatory leadership
What a senior fractional lead should actually own, establish and transfer.
Explore TALENT STRATEGYFractional expert, project pod or permanent hire?
Choose the model from the work, duration and decision rights—not habit.
ExploreEDITORIAL STANDARD
Fewer, stronger publications
VED will publish only where its drug-development, regulatory, talent or AI-assurance perspective adds a useful decision framework. Every piece should create a credible reason for a biotech leader, AI founder or investor to start a conversation.
Start with the constraint
What must your programme decide, prove or deliver next?
Share the situation, evidence and timing. We will propose the smallest credible first step.